Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000173112223002036 Filed on November 07, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.80M	$15.34M	$12.77M
YoY Change	0.28%	10.0%
Cash & Equivalents	$9.822M	$5.439M	$12.77M
Short-Term Investments	$2.982M	$9.897M
Other Short-Term Assets	$73.51K	$130.0K	$519.7K
YoY Change	-85.86%	-70.9%
Inventory	$493.5K	$777.8K
Prepaid Expenses
Receivables	$0.00
Other Receivables
Total Short-Term Assets	$13.37M	$16.24M	$13.29M
YoY Change	0.63%	12.9%	602.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.469M	$1.052M	$765.4K
YoY Change	353.22%	66.64%	224.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.520K	$10.00K	$7.520K
YoY Change	0.0%
Other Assets			$0.00
YoY Change
Total Long-Term Assets	$3.552M	$1.157M	$935.0K
YoY Change	279.86%	83.23%	174.14%
TOTAL ASSETS
Total Short-Term Assets	$13.37M	$16.24M	$13.29M
Total Long-Term Assets	$3.552M	$1.157M	$935.0K
Total Assets	$16.92M	$17.40M	$14.22M
YoY Change	18.98%	15.85%	536.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$86.82K	$38.51K	$99.03K
YoY Change	-12.33%	-2.46%	642.73%
Accrued Expenses	$462.4K	$73.90K	$92.77K
YoY Change	398.43%	532.15%	164.08%
Deferred Revenue	$5.700K		$5.300K
YoY Change	7.55%
Short-Term Debt	$201.9K	$0.00	$169.9K
YoY Change	18.84%	-100.0%
Long-Term Debt Due	$17.31K	$20.00K
YoY Change
Total Short-Term Liabilities	$842.6K	$226.4K	$453.2K
YoY Change	85.92%	14.77%	-34.36%
LONG-TERM LIABILITIES
Long-Term Debt	$58.72K	$60.00K	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$68.53K
YoY Change	-100.0%
Total Long-Term Liabilities	$58.72K	$63.33K	$68.53K
YoY Change	-14.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$842.6K	$226.4K	$453.2K
Total Long-Term Liabilities	$58.72K	$63.33K	$68.53K
Total Liabilities	$901.3K	$289.7K	$521.7K
YoY Change	72.76%	46.88%	-24.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.02M	-$8.623M	-$4.088M
YoY Change	145.15%	223.34%	793.37%
Common Stock	$15.78K	$15.78K	$10.45K
YoY Change	51.04%	51.04%	49.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$21.38K
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.02M	$17.11M	$13.70M
YoY Change
Total Liabilities & Shareholders Equity	$16.92M	$17.40M	$14.22M
YoY Change	18.98%	15.85%	536.95%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001901305
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2022Q4	FRZA	Due From Twin Vee DueFromTwinVee		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q3	FRZA	Due To Twin Vee DueToTwinVee		usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2022Q3	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
	dei	Trading Symbol TradingSymbol	FRZA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2022Q3	FRZA	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment		usd
	FRZA	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment		usd
CY2022Q3	FRZA	Realized Gain Loss On Investments RealizedGainLossOnInvestments		usd
	FRZA	Realized Gain Loss On Investments RealizedGainLossOnInvestments		usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	FRZA	Change In Rou Lease Asset ChangeInRouLeaseAsset		usd
	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale		usd
	FRZA	Gain Loss On Disposition Of Asset GainLossOnDispositionOfAsset		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	FRZA	Realized Gains On Marketable Securities Available For Sale RealizedGainsOnMarketableSecuritiesAvailableForSale		usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
	FRZA	Finance Lease Liabilities FinanceLeaseLiabilities		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities		usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2022	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41469
	dei	Entity Registrant Name EntityRegistrantName	FORZA X1, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3159685
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
	dei	City Area Code CityAreaCode	(772)
	dei	Local Phone Number LocalPhoneNumber	429-2525
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15762750	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5438820	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9896520	usd
CY2023Q3	FRZA	Due From Twin Vee DueFromTwinVee	4618	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	777831	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	124996	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	519735	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	16242785	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13286934	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1051936	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	765406	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7517	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7517	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97200	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1156653	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	934992	usd
CY2023Q3	us-gaap	Assets Assets	17399438	usd
CY2022Q4	us-gaap	Assets Assets	14221926	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	38513	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	99028	usd
CY2022Q4	FRZA	Due To Twin Vee DueToTwinVee	169851	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73898	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	5800	usd
CY2022Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	5300	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	90924	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17233	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	226368	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	453191	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	63328	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	63328	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	68532	usd
CY2023Q3	us-gaap	Liabilities Liabilities	289696	usd
CY2022Q4	us-gaap	Liabilities Liabilities	521723	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2023Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	15784000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10450000	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	10450000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10450	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25716690	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17777385	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8622732	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4087632	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	17109742	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17399438	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14221926	usd
CY2023Q3	us-gaap	Revenues Revenues	18559	usd
	us-gaap	Revenues Revenues	18559	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	11621	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	66543	usd
	us-gaap	Cost Of Revenue CostOfRevenue	102358	usd
	us-gaap	Cost Of Revenue CostOfRevenue	90633	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6938	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-66543	usd
	us-gaap	Gross Profit GrossProfit	-83799	usd
	us-gaap	Gross Profit GrossProfit	-90633	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	217455	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	125851	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	906432	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	267657	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	837857	usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages	515833	usd
	us-gaap	Salaries And Wages SalariesAndWages	2565460	usd
	us-gaap	Salaries And Wages SalariesAndWages	994982	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	92505	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	35221	usd
	us-gaap	Professional Fees ProfessionalFees	286411	usd
	us-gaap	Professional Fees ProfessionalFees	70831	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60667	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283936	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1024787	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	718375	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50482	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18744	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	134408	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37816	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1258966	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	979585	usd
	us-gaap	Operating Expenses OperatingExpenses	4917498	usd
	us-gaap	Operating Expenses OperatingExpenses	2089661	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1252028	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1046128	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5001297	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2180294	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1401	usd
CY2022Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	4577	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	1401	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4608	usd
CY2023Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	150284	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	412551	usd
CY2023Q3	FRZA	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	31426	usd
	FRZA	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	31426	usd
CY2023Q3	FRZA	Realized Gain Loss On Investments RealizedGainLossOnInvestments	23747	usd
	FRZA	Realized Gain Loss On Investments RealizedGainLossOnInvestments	23747	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1144	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1112	usd
	us-gaap	Interest Expense InterestExpense	2928	usd
	us-gaap	Interest Expense InterestExpense	1970	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-31582	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	205714	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3465	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	466197	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28944	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1046314	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1042663	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4535100	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2209238	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15784000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8837470	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12579866	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7619275	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1542449	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-514292	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1028157	usd
CY2022Q2	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	500000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-652283	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	875874	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14829489	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	158705	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1042663	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	14821405	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341163	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2005132	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6929552	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341817	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1483654	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17823949	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	332107	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1046314	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	17109742	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4535100	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2209238	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134408	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37816	usd
	FRZA	Change In Rou Lease Asset ChangeInRouLeaseAsset	64869	usd
	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale	31426	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1015087	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	158705	usd
	FRZA	Gain Loss On Disposition Of Asset GainLossOnDispositionOfAsset	31582	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	777831	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-394739	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	358208	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-60515	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	26151	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-18869	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-23438	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	500	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4900	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-63853	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3877991	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2331730	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	328534	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	465086	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9841346	usd
	FRZA	Realized Gains On Marketable Securities Available For Sale RealizedGainsOnMarketableSecuritiesAvailableForSale	23747	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10193627	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-465086	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6996015	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15231350	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	66463	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	296361	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	500000	usd
	FRZA	Finance Lease Liabilities FinanceLeaseLiabilities	11844	usd
	FRZA	Due To Related Party Twin Vee DueToRelatedPartyTwinVee	755299	usd
	FRZA	Due To Related Party Twin Vee DueToRelatedPartyTwinVee	890198	usd
	FRZA	Due From Related Party Twin Vee DueFromRelatedPartyTwinVee	580830	usd
	FRZA	Due From Related Party Twin Vee DueFromRelatedPartyTwinVee	389446	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6743239	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14934237	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7328379	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12137421	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1803285	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5438820	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13940706	usd
	us-gaap	Interest Paid Net InterestPaidNet	2928	usd
	us-gaap	Interest Paid Net InterestPaidNet	1970	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	92405	usd
CY2023Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	5800	usd
CY2022Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	5300	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zFhsPE563WX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_z3rChCzOYlzc">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5438820	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zZcOa56ClL7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zwfHBWKP4cvi">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_909_ecustom--FdicInsuredLimit_iI_pp0p0_c20230930_zOIw4A2DOI88" title="FDIC insured limit">250,000 </span>are at risk. At September 30, 2023 and December 31, 2022, the Company had $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zTUaPfg0s5Di" title="FDIC excess amount">5,108,626</span> and $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zris52798WQd" title="FDIC excess amount">12,446,216</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q3	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	5108626	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	12446216	usd
CY2023Q3	us-gaap	Other Inventory OtherInventory	90085	usd
CY2022Q4	us-gaap	Other Inventory OtherInventory	0	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	182919	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	48511	usd
CY2023Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1051936	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	765406	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50482	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18744	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	134408	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37816	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	9896520	usd
CY2022Q4	FRZA	Treasury Stock Acquired Average Cost Precentage TreasuryStockAcquiredAverageCostPrecentage	0.0033	pure
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P2Y
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7517	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97200	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	90924	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	90924	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154777	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	23226	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	69680	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	92906	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1982	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	90924	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P0Y11M15D
	us-gaap	Operating Lease Cost OperatingLeaseCost	67650	usd
	us-gaap	Lease Cost LeaseCost	67650	usd
CY2023Q1	FRZA	Net Asset Value NetAssetValue	48826	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2023Q1	FRZA	Net Asset Value NetAssetValue	43579	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17233	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	63328	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	5237	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	20950	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20950	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	20950	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	20945	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.12	pure
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	875	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	89907	usd
CY2023Q3	FRZA	Finance Lease Imputed Interest FinanceLeaseImputedInterest	9346	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	80561	usd
	us-gaap	Revenues Revenues	18559	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	755299	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	890198	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	580830	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	389446	usd
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2500	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2536	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	12500	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2536	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	28748	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	56581	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	45150	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36186	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73898	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5438820	usd
CY2023Q3	FRZA	Working Capital WorkingCapital	16016417	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2022Q4	FRZA	Working Capital WorkingCapital	12833743	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1046314	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1042663	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4535100	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2209238	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	306705	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
CY2023Q3	FRZA	Warrant Activity WarrantActivity	0	shares
	FRZA	Warrant Activity WarrantActivity	0	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	332107	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	158705	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1015087	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	158705	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.15	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0362	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1441500	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.41
CY2022	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P10Y
CY2022	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	4009913	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
	FRZA	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Option Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionWeightedAverageRemainingContractualTerm2	P9Y11M19D
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	44722	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.33
	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y7M28D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1396778	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.48
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y3D
CY2023Q3	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	476639	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.85
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y11M23D

Files In Submission

Name	View Source	Status
frza-20230930_lab.xml	Edgar Link	unprocessable
0001731122-23-002036-index-headers.html	Edgar Link	pending
0001731122-23-002036-index.html	Edgar Link	pending
0001731122-23-002036.txt	Edgar Link	pending
0001731122-23-002036-xbrl.zip	Edgar Link	pending
e5183_10q.htm	Edgar Link	pending
e5183_ex31-1.htm	Edgar Link	pending
e5183_ex31-2.htm	Edgar Link	pending
e5183_ex32-1.htm	Edgar Link	pending
e5183_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frza-20230930_cal.xml	Edgar Link	unprocessable
frza-20230930_def.xml	Edgar Link	unprocessable
frza-20230930_pre.xml	Edgar Link	unprocessable
e5183_10q_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2023 Q4 Form 10-Q Financial Statement

#000173112223002036 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission